Skip to main content

Professor and Co-Director

Research Description

We seek to understand the pathophysiology underlying monogenic neurodevelopmental disorders, and we use this information to develop therapeutics to treat these disorders.  To accomplish these goals, we employ a variety of techniques: electrophysiology, biochemistry, molecular biology, optogenetics, behavioral phenotyping, gene therapy, and small-molecule drug screening.  We are particularly focused on developing transformative treatments for Dup15q syndrome, Pitt-Hopkins syndrome, and Angelman syndrome.



Ben Philpot, PhD